List of Tables
Table 1. Lancets CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
Table 2. Lancets Market Trends
Table 3. Lancets Market Drivers
Table 4. Lancets Market Challenges
Table 5. Lancets Market Restraints
Table 6. Global Lancets Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Lancets Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Lancets Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Lancets Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Lancets, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Lancets Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Lancets Revenue Share by Manufacturer, 2018-2023
Table 13. Global Lancets Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Lancets Sales Share by Manufacturer, 2018-2023
Table 15. Global Lancets Price by Manufacturer (2018-2023) & (USD/Unit)
Table 16. Global Lancets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lancets as of 2022)
Table 18. Global Key Manufacturers of Lancets, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Lancets, Product Offered and Application
Table 20. Global Key Manufacturers of Lancets, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Lancets in India, Ranked by Revenue (2022) & (US$ million)
Table 23. India Lancets Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Lancets Revenue Share by Players, (2018-2023)
Table 25. India Lancets Sales by Players, (K Units), (2018-2023)
Table 26. India Lancets Sales Share by Players, (2018-2023)
Table 27. Global Lancets Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Lancets Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Lancets Sales in Volume Forecast by Region (2024-2029) & (K Units)
Table 30. Global Lancets Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Lancets Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Lancets Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Lancets Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Lancets Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Lancets Sales in Volume by Country (2024-2029) & (K Units)
Table 37. EMEA Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Lancets Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Lancets Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Lancets Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Lancets Sales in Volume by Country (2024-2029) & (K Units)
Table 42. APAC Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Lancets Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Lancets Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Lancets Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Lancets Sales in Volume by Country (2024-2029) & (K Units)
Table 47. Roche Company Information
Table 48. Roche Description and Business Overview
Table 49. Roche Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 50. Roche Lancets Product
Table 51. Roche Recent Development
Table 52. Lifescan Company Information
Table 53. Lifescan Description and Business Overview
Table 54. Lifescan Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 55. Lifescan Lancets Product
Table 56. Lifescan Recent Development
Table 57. BD Company Information
Table 58. BD Description and Business Overview
Table 59. BD Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 60. BD Lancets Product
Table 61. BD Recent Development
Table 62. Ascensia Company Information
Table 63. Ascensia Description and Business Overview
Table 64. Ascensia Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 65. Ascensia Lancets Product
Table 66. Ascensia Recent Development
Table 67. Abbott Company Information
Table 68. Abbott Description and Business Overview
Table 69. Abbott Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 70. Abbott Lancets Product
Table 71. Abbott Recent Development
Table 72. B. Braun Company Information
Table 73. B. Braun Description and Business Overview
Table 74. B. Braun Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 75. B. Braun Lancets Product
Table 76. B. Braun Recent Development
Table 77. ARKRAY Company Information
Table 78. ARKRAY Description and Business Overview
Table 79. ARKRAY Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 80. ARKRAY Lancets Product
Table 81. ARKRAY Recent Development
Table 82. Terumo Company Information
Table 83. Terumo Description and Business Overview
Table 84. Terumo Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 85. Terumo Lancets Product
Table 86. Terumo Recent Development
Table 87. I-SENS Company Information
Table 88. I-SENS Description and Business Overview
Table 89. I-SENS Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 90. I-SENS Lancets Product
Table 91. I-SENS Recent Development
Table 92. Nipro Company Information
Table 93. Nipro Description and Business Overview
Table 94. Nipro Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 95. Nipro Lancets Product
Table 96. Nipro Recent Development
Table 97. Omron Company Information
Table 98. Omron Description and Business Overview
Table 99. Omron Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 100. Omron Lancets Product
Table 101. Omron Recent Development
Table 102. AgaMatrix Company Information
Table 103. AgaMatrix Description and Business Overview
Table 104. AgaMatrix Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 105. AgaMatrix Lancets Product
Table 106. AgaMatrix Recent Development
Table 107. Smiths Medical Company Information
Table 108. Smiths Medical Description and Business Overview
Table 109. Smiths Medical Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Smiths Medical Lancets Product
Table 111. Smiths Medical Recent Development
Table 112. Sarstedt Company Information
Table 113. Sarstedt Description and Business Overview
Table 114. Sarstedt Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Sarstedt Lancets Product
Table 116. Sarstedt Recent Development
Table 117. Sinocare Company Information
Table 118. Sinocare Description and Business Overview
Table 119. Sinocare Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Sinocare Lancets Product
Table 121. Sinocare Recent Development
Table 122. Yicheng Company Information
Table 123. Yicheng Description and Business Overview
Table 124. Yicheng Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Yicheng Lancets Product
Table 126. Yicheng Recent Development
Table 127. Yuwell Company Information
Table 128. Yuwell Description and Business Overview
Table 129. Yuwell Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Yuwell Lancets Product
Table 131. Yuwell Recent Development
Table 132. Greiner Bio One Company Information
Table 133. Greiner Bio One Description and Business Overview
Table 134. Greiner Bio One Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Greiner Bio One Lancets Product
Table 136. Greiner Bio One Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Lancets Customers List
Table 140. Lancets Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Lancets Product Picture
Figure 2. Global Lancets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Lancets Market Size 2018-2029 (US$ Million)
Figure 4. Global Lancets Sales 2018-2029 (K Units)
Figure 5. India Lancets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. India Lancets Market Size 2018-2029 (US$ Million)
Figure 7. India Lancets Sales 2018-2029 (K Units)
Figure 8. India Lancets Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. India Lancets Market Share in Global, in Volume (K Units) 2018-2029
Figure 10. Lancets Report Years Considered
Figure 11. Product Picture of Safety Lancets
Figure 12. Product Picture of Ordinary Lancets
Figure 13. Global Lancets Market Share by Type in 2022 & 2029
Figure 14. Global Lancets Sales in Value by Type (2018-2029) & (US$ Million)
Figure 15. Global Lancets Sales Market Share in Value by Type (2018-2029)
Figure 16. Global Lancets Sales by Type (2018-2029) & (K Units)
Figure 17. Global Lancets Sales Market Share in Volume by Type (2018-2029)
Figure 18. Global Lancets Price by Type (2018-2029) & (USD/Unit)
Figure 19. India Lancets Market Share by Type in 2022 & 2029
Figure 20. India Lancets Sales in Value by Type (2018-2029) & (US$ Million)
Figure 21. India Lancets Sales Market Share in Value by Type (2018-2029)
Figure 22. India Lancets Sales by Type (2018-2029) & (K Units)
Figure 23. India Lancets Sales Market Share in Volume by Type (2018-2029)
Figure 24. India Lancets Price by Type (2018-2029) & (USD/Unit)
Figure 25. Product Picture of Cholesterol Tests
Figure 26. Product Picture of Glucose Tests
Figure 27. Product Picture of Others
Figure 28. Global Lancets Market Share by Application in 2022 & 2029
Figure 29. Global Lancets Sales in Value by Application (2018-2029) & (US$ Million)
Figure 30. Global Lancets Sales Market Share in Value by Application (2018-2029)
Figure 31. Global Lancets Sales by Application (2018-2029) & (K Units)
Figure 32. Global Lancets Sales Market Share in Volume by Application (2018-2029)
Figure 33. Global Lancets Price by Application (2018-2029) & (USD/Unit)
Figure 34. India Lancets Market Share by Application in 2022 & 2029
Figure 35. India Lancets Sales in Value by Application (2018-2029) & (US$ Million)
Figure 36. India Lancets Sales Market Share in Value by Application (2018-2029)
Figure 37. India Lancets Sales by Application (2018-2029) & (K Units)
Figure 38. India Lancets Sales Market Share in Volume by Application (2018-2029)
Figure 39. India Lancets Price by Application (2018-2029) & (USD/Unit)
Figure 40. Americas Lancets Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 41. Americas Lancets Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 42. Americas Lancets Sales by Type (2018-2029) & (K Units)
Figure 43. Americas Lancets Sales Market Share in Volume by Type (2018-2029)
Figure 44. Americas Lancets Sales by Application (2018-2029) & (K Units)
Figure 45. Americas Lancets Sales Market Share in Volume by Application (2018-2029)
Figure 46. United States Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 47. Canada Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 48. Mexico Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. EMEA Lancets Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 51. EMEA Lancets Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 52. EMEA Lancets Sales by Type (2018-2029) & (K Units)
Figure 53. EMEA Lancets Sales Market Share in Volume by Type (2018-2029)
Figure 54. EMEA Lancets Sales by Application (2018-2029) & (K Units)
Figure 55. EMEA Lancets Sales Market Share in Volume by Application (2018-2029)
Figure 56. Europe Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 57. Middle East Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 58. Africa Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 59. China Lancets Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 60. China Lancets Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 61. China Lancets Sales by Type (2018-2029) & (K Units)
Figure 62. China Lancets Sales Market Share in Volume by Type (2018-2029)
Figure 63. China Lancets Sales by Application (2018-2029) & (K Units)
Figure 64. China Lancets Sales Market Share in Volume by Application (2018-2029)
Figure 65. APAC Lancets Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 66. APAC Lancets Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 67. APAC Lancets Sales by Type (2018-2029) & (K Units)
Figure 68. APAC Lancets Sales Market Share in Volume by Type (2018-2029)
Figure 69. APAC Lancets Sales by Application (2018-2029) & (K Units)
Figure 70. APAC Lancets Sales Market Share in Volume by Application (2018-2029)
Figure 71. Japan Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 72. South Korea Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 73. China Taiwan Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. Southeast Asia Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. India Lancets Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. Lancets Value Chain
Figure 77. Lancets Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
